
Vincent Charles Marconi MD
Professor, Medicine, Emory University School of Medicine
Join to view full profile
1670 Clairmont RdDecatur, GA 30033
Phone+1 404-321-6111
Dr. Marconi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 2003 - 2005
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2000 - 2003
Johns Hopkins University School of MedicineClass of 2000
Certifications & Licensure
GA State Medical License 2009 - 2027
MA State Medical License 2002 - 2011
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
- CMS Meaningful Use Stage 1 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2017
Clinical Trials
Publications & Presentations
PubMed
- Microbiome-derived metabolites shape CD4+ T cell differentiation and immune aging in HIV-1 infection.Amanda Cabral Da Silva, Luke Flantzer, Jaclyn Weinberg, Shuya Kyu, Lisa P Daley-Bauer
JCI Insight. 2026-08-24 - COVID-19 vaccination among people with HIV in Uganda: lessons from a high-risk group with high vaccine uptake for the next pandemic.Taing Nandi Aung, Winnie Muyindike, Susanne S Hoeppner, Victoria Nanfuka, Nimusiima Komukama
Vaccine. 2026-08-13 - Protective Effect of the APOL1 p.N264K Variant Against CKD among People with HIV Carrying APOL1 High-Risk Genotypes.Junyu Chen, Jennie Mather, Rachel K Y Hung, Qin Hui, Cheryl Winkler
Journal of the American Society of Nephrology. 2026-08-03
Press Mentions
Third Transplant Patient Cured of HIV Marks Important FirstsFebruary 16th, 2022
Study Shows Benefit of Baricitinib for Ventilated COVID PatientsFebruary 14th, 2022
Emory Launches Study to Understand Long COVID-19 as Part of a Nationwide InitiativeNovember 4th, 2021
Grant Support
- REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRDVANDERBILT UNIVERSITY MEDICAL CENTER2024–2028
- Phase II study to evaluate the efficacy and safety of baricitinib for reduction of HIV in the central nervous systemEMORY UNIVERSITY2022–2027
- Host Genetic and Epigenetic Factors of the Progression, Comorbidities and Outcomes of Viral InfectionVETERANS HEALTH ADMINISTRATION2022–2026
- Multi-omic Predictors of Renal Function among HIV-infected Individuals of African AncestryEMORY UNIVERSITY2020–2025
- Integrating HIV and hEART health in South Africa (iHeart-SA)WITS HEALTH CONSORTIUM (PTY), LTD2020–2025
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









